SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-287844
Filing Date
2017-09-19
Accepted
2017-09-19 08:33:33
Documents
3
Period of Report
2017-09-14
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d455362d8k.htm 8-K 17588
2 EX-99.1 d455362dex991.htm EX-99.1 17721
3 GRAPHIC g455362g11f54.gif GRAPHIC 4771
  Complete submission text file 0001193125-17-287844.txt   43456
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10352 | Film No.: 171091129
SIC: 2834 Pharmaceutical Preparations